ISRCTN20328848已完成未知
Primary Prevention Of Psychosis through interventions in the symptomatic prodromal phase. A pragmatic Norwegian Ultra High Risk study.
Stavanger University Hospital (Norway)0 个研究点目标入组 240 人开始时间: 2014年10月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Incidence study inclusion criteria:
- •1. The patient is listed in the national register and residing in the catchment areas of Stavanger, Fonna, Bergen, and Østfold
- •2. Between 13 and 65 years
- •3. Meet diagnostic criteria in DSM-IV for first episode schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, brief psychotic disorder, affective psychoses (Bipolar I disorder, Bipolar II disorder with psychotic symptoms, Major depressive disorder with psychotic symptoms) or psychotic disorders NOS
- •4. The patient is (or has recently been) active psychotic with symptoms of delusions, hallucinations, disturbed thinking, unsuitable/bizarre behaviour which cannot clearly be explained by organic reasons. The symptoms must have lasted the whole day for several days or several times a week for several weeks, not limited to some brief moments corresponding to a score of at least 4 on one or more of the following positive and negative symptom scale (PANSS) symptoms: P1 (delusions), P3 hallucinations), P5 (grandiose thinking), P6 (suspiciousness) and G9 (unusual thought content); 5. This is the first episode of the condition that is being adequately treated. i.e. the patient has not received antipsychotic treatment corresponding to 75% of a defined daily dosage for more than eight weeks (shorter if the symptoms remit)
- •6. There are no known neurological or endocrine disorders that may have caused the presenting psychotic symptoms
- •7. The patient is not mentally retarded with an IQ below 70
- •8. Able to understand and speak Norwegian
- •9. Able to understand and sign informed consent/assent for minors' document.
- •Prodromal inclusion and exclusion criteria
- •1. The patient is listed in the national register and residing in the catchment areas of: Stavanger and Fonna
- •2. Between 13 and 65 years
- •3. Meet diagnostic criteria for prodromal syndrome SIPS criteria
- •4. Does not meet current or life-time criteria for any psychotic disorder
- •5. The symptoms are not better accounted for by an axis I, axis II or substance use disorder with the exception of schizotypal personality disorder (the presence of any of these disorders in itself is not an automatic reason for exclusion)
- •6. Does not use any antipsychotic medication currently and have not used antipsychotic medication (regardless of dosage) for more than four weeks lifetime
- •7. No known neurological or endocrine disorders that may have caused the presenting psychotic symptoms
- •8.The patient is not mentally retarded with an IQ below 70
- •9. The patient must be able to understand and speak Norwegian
- •10. The patient must be able to understand and sign an informed consent or assent for minors' document
排除标准
- •All referals not fullfilling inclusion criteria described above
研究者
相似试验
已完成
不适用
The prevention of psychosis in at risk mental stateMental disorderISRCTN21353122The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)240
已完成
不适用
Prevention of psychosis with a cognitive behavioural intervention in help-seeking young people with an at risk mental state for developing psychosisNL-OMON31359Parnassia (Den Haag)240
已完成
4 期
Second generation intervention research in the pre-psychotic phase of illness in schizophrenia and related psychosesSchizophrenia and other psychotic disordersMental Health - SchizophreniaMental Health - Other mental health disordersACTRN12605000247673Janssen-Cilag Pharmaceuticals119
招募中
3 期
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trialinvestigating the efficacy of N-Acetylcysteine (NAC) and Integrated Preventive PsychologicalIntervention (IPPI) in Subjects Clinically at High Risk for PsychosisSubjects presenting ultra-high risk (UHR) for psychosis (e.g. attenuated psychotic symptoms, brief limited intermittend psychotic symptoms or a genetic risk in combination with a decline in social functioning)DRKS00010952Zentralinstitut für seelische Gesundheit/Central Institute of Mental Health (ZI)200
进行中（未招募）
1 期
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trial investigating the efficacy of Acetylcysteine (ACC) and Integrated Preventive Psychological Intervention (IPPI) in Subjects Clinically at High Risk for PsychosisEUCTR2014-003076-22-DECentral Institute of Mental Health Mannheim (ZI)130